Cardiovascular System

Description

Cardiovascular System Acute Coronary Syndromes (ACS) Overview and Pathophysiology Acute Coronary Syndromes (ACS) represent a spectrum of life-threatening cardiac conditions resulting from sudden reduction or blockage of blood flow to the myocardium. These are among the most frequently tested cardiac emergencies on the CCRN exam due to their prevalence in ICU settings and their potential for rapid deterioration. ACS includes three clinical entities, all of which share a common pathophysiological trigger-plaque rupture and thrombus formation in a coronary artery: ◦Unstable Angina (UA)
Non-ST Elevation Myocardial Infarction (NSTEMI) ◦ST-Elevation Myocardial Infarction (STEMI) The key difference among these lies in the degree of coronary artery occlusion and myocardial injury. Pathophysiology ACS begins with the rupture of an atherosclerotic plaque within a coronary artery. This event exposes subendothelial components to the bloodstream, triggering: Platelet adhesion and aggregation ◦Thrombin activation and fibrin formation ◦Vasoconstriction and thrombus propagation This culminates in a partial or complete occlusion of the coronary artery, depriving myocardial tissue of oxygen and nutrients. ◦In Unstable Angina, there is partial occlusion of a coronary artery but no myocardial necrosis. Therefore, cardiac biomarkers (troponin, CK-MB) remain normal, though the patient experiences ischemic symptoms. ◦In NSTEMI, the occlusion remains partial or transient, but myocardial infarction occurs, evidenced by elevated troponin levels. However, there is no ST elevation on ECG, because the infarction is usually subendocardial (not full thickness). In STEMI, the thrombus leads to a complete occlusion, causing a transmural infarction-full-thickness death of myocardial tissue. This is visible on ECG as ST-segment elevation and requires urgent reperfusion therapy to salvage myocardium and prevent death. Key Differences Type Unstable Angina Biomarkers= Normal ECG Findings =ST depression/T-wave inversion Degree of Occlusion= Partial, transient NSTEMI Biomarkers= elevated Troponin ECG Findings =ST depression/T-wave inversion Degree of Occlusion= Partial, prolonged STEMI Biomarkers= elevated Troponin ECG Findings = ST Elevation, Q waves Degree of Occlusion= COMPLETE Clinical relevance: The earlier the occlusion is reversed, the more myocardium is preserved The longer the delay, the greater the infarct size, and the higher the risk for arrhythmias, hear failure, cardiogenic shock, and death. On the CCRN exam, expect to be tested on: ◦Differentiating ACS types using ECG and troponin levels ◦Recognizing hemodynamic instability or complications Knowing which patients need immediate PCI or thrombolytics Signs/Labs Recognizing the clinical presentation and correlating it with laboratory and ECG findings is critical for early identification and management of Acute Coronary Syndromes (ACS)- a key expectation for ICU nurses and a high-yield topic on the CCRN exam. Clinical Signs & Symptoms Most patients with ACS present with some form of chest discomfort, but the presentation can be atypical, especially in older adults, diabetics, and women. Classic symptoms include: ◦Chest pain or pressure
Typically retrosternal, may radiate to left arm, neck, jaw, or back. Often described as crushing, squeezing, or heavy. Lasts >20 minutes, not relieved by rest or nitroglycerin (in MI). ◦Shortness of breath (SOB)
May indicate heart failure or pulmonary congestion. ◦Diaphoresis (sweating)
A sympathetic response to pain or hemodynamic instability. ◦Nausea, vomiting, anxiety, or syncope
Frequently reported, especially in inferior wall MI. Fatigue or weakness
Especially in elderly patients or those with silent ischemia. Electrocardiogram (ECG) Findings The 12-lead BCG is the first-line diagnostic tool and should be obtained within 10 minutes of patient: ECG Finding Interpretation ST elevation ≥1 mm STEMI (transmural infarction) ST depression NSTEMI or unstable angina T-wave inversion Ischemia or evolving infarct Q waves (late sign) Previous infarction or late STEMI New LBBB May be equivalent to STEMI Key diagnostic clue: ST elevation in contiguous leads + troponin rise = STEMI → urgent PCI or thrombolytics. ST depression or T-wave inversion + troponin elevation = NSTEMI → non-emergent PCI, medical therapy. Laboratory Markers Cardiac biomarkers help confirm the diagnosis and stratify risk: ◦Troponin I /T (most specific):
Rises 3-6 hours after symptom onset. Peaks at 12-24 hours, may stay elevated for 7-10 days.
Elevated in NSTEMI and STEMI, normal in unstable angina. ◦CK-MB (less specific):
Rises earlier but returns to normal faster. Can be helpful to identify reinfarction. ◦BNP or NT-proBNP:
 May be elevated if LV dysfunction or heart failure is present. Clinical decision point: If troponin is negative but symptoms and ECG are suggestive of ischemia, repeat testing every 6 hours to capture delayed elevation. Other Supporting Tests ◦Chest X-ray (CXR): To rule out other causes of chest pain (e.g., pneumothorax, aortic dissection). ◦Echocardiogram: May show wall motion abnormalities in the affected area. ◦Coronary angiography: Definitive test for diagnosis and treatment planning. CCRN Exam Insight A patient with chest pain, diaphoresis, ST elevation, and elevated troponin is a classic STEMI-needs immediate reperfusion. If troponin is elevated but there's no ST elevation, it's NSTEMI-requires urgent but not emergent PCI. Treatment Management of Acute Coronary Syndromes (ACS) is time-sensitive and varies depending on whether the patient is experiencing unstable angina, NSTEMI, or STEMI. The goals are to relieve ischemia, restore perfusion, and prevent further thrombus formation or myocardial damage. Initial Medical Therapy (MONA) The mnemonic "MONA" helps remember the key components of immediate treatment: ◦Morphine: Provides analgesia, reduces anxiety, and decreases sympathetic tone. It also reduces preload via venodilation. Use cautiously-avoid in hypotension or right ventricular infarction. ◦Oxygen: Administer only if SpO2 < 90%, respiratory distress is present, or there are signs of hypoxemia. Routine oxygen in normoxic patients may cause harm. ◦Nitrates: Sublingual or IV nitroglycerin can relieve chest pain and reduce preload.
Contraindicated in hypotension, bradycardia, or recent use of phosphodiesterase inhibitors (e.g., sildenafil). ◦Aspirin: Give immediately unless contraindicated. Use 162-325 mg to inhibit platelet aggregation. Chewable form preferred for faster absorption. Reperfusion Strategies Restoring coronary blood flow is essential, especially in STEMI: ◦Percutaneous Coronary Intervention (PCI): Gold standard in STEMI if available within 90 minutes (door-to-balloon time). Also considered in high-risk NSTEMI. ◦Thrombolytics (fibrinolytics): Used only in STEMI if PCI unavailable within timeframe.
Most effective within 3 hours of symptom onset. Contraindicated in recent surgery, bleeding disorders, or stroke. ◦NSTEMI/Unstable Angina: Typically managed with medical therapy first, then risk stratification to determine need for early PCI. Antithrombotic and Anti-Ischemic Therapy ◦Antiplatelets: ◦Aspirin: continue indefinitely. ◦P2Y12 inhibitors (e.g., clopidogrel, ticagrelor): added to aspirin for due antiplatelet therapy (DAPT), especially post-PCI. ◦Anticoagulants: ◦Heparin (unfractionated or LMWH) to reduce clot propagation. ◦Bivalirudin or fondaparinux may be used depending on setting and risk profile. ◦Beta-blockers: ◦Reduce myocardial oxygen demand by decreasing HR and BP. • Contraindicated in acute decompensated heart failure, bradycardia, or sever hypotension. • Statins: ◦Initiated early regardless of cholesterol level. High-intensity statin therapy improves long-term outcomes. ◦ACE inhibitors or ARBs: ◦Initiated within 24 hours if LV dysfunction, heart failure, or anterior MI is present. Nursing Priorities ◦Monitor for recurrent chest pain or ECG changes. ◦Serial troponins to assess for infarct progression. ◦Continuous telemetry for arrhythmias. ◦Watch for signs of bleeding if thrombolytics or anticoagulants are used. ◦Educate patient on the importance of medication adherence and risk factor modification. Clinical decision point: For CCRN exam purposes, know that STEMI requires immediate PCI or thrombolytics, while NSTEMI is usually treated with medical management followed by PCI based on risk. Oxygen is no longer routinely given unless hypoxic-don't miss this update. Complications Acute Coronary Syndromes (ACS) can lead to multiple life-threatening complications, especially if reperfusion is delayed. Early recognition of these complications is crucial, as many are time-sensitive and can worsen mortality. The CCRN exam frequently tests on how to identify and intervene in these high-risk situations. 1.Arrhythmias The most common complication following a myocardial infarction (MI). The type depends on the location and size of the infarct: ◦Ventricular arrhythmias: VT and VF are common in the first 48 hours post-MI due to myocardial irritability. Require defibrillation if pulseless. ◦Bradyarrhythmias: Seen especially in inferior wall MI due to AV node ischemia. Can require atropine or pacing. ◦Atrial fibrillation: May occur from atrial ischemia or increased left atrial pressure. Can compromise cardiac output if rapid or persistent. ◦Premature ventricular contractions (PVCs): May precede more serious arrhythmias-monitor closely. Monitor all post-MI patients with continuous ECG and be prepared to follow ACLS protocols. 2. Pericarditis Inflammation of the pericardial sac following MI is referred to as post-infarction pericarditis or Dresser's syndrome (delayed form). ◦Typically occurs 2-4 days post-MI (early) or weeks later (Dresser's). Symptoms include pleuritic chest pain (worse when lying flat), pericardial friction rub, and diffuse ST elevation on ECG (not localized like in STEMI). • Treatment includes NSAIDs for inflammation and pain. Avoid anticoagulation unless strongly indicated, due to bleeding risk. Recognizing this complication is essential because it can mimic reinfarction but has a different ECG pattern and treatment approach. 3. Papillary Muscle Rupture A rare but catastrophic mechanical complication, typically occurring within 3-7 days post-MI, especially after an inferior MI affecting the posterior papillary muscle. ◦Leads to acute mitral regurgitation → sudden pulmonary edema, hypotension, and cardiogenic shock. ◦Physical exam may reveal a new, loud systolic murmur at the apex, often accompanied by signs of left heart failure. • Diagnosis confirmed by emergent echocardiogram showing flail mitral valve or regurgitant jet. • Requires urgent surgical intervention -mortality is extremely high without repair. Other Notable Complications to Know ◦Heart failure and cardiogenic shock: due to large infarct size and poor contractility. ◦Ventricular septal rupture: causes new harsh systolic murmur and biventricular failure.
Left ventricular aneurysm: may form weeks after MI; can lead to embolic events or heart failure. ◦ Clinical decision point: If a post-MI patient develops hypotension, dyspnea, and a new murmur- think papillary muscle rupture or ventricular septal defect. If they have chest pain with diffuse ST elevation and friction rub- think pericarditis, not reinfarction. These complications are classic "board-style" scenarios-recognizing the clues can make or break your score. Dysrhythmias Overview and Pathophysiology Dysrhythmias are among the most frequently tested topics on the CCRN exam-and for good reason. In the ICU, arrhythmias are common, potentially life-threatening, and demand immediate recognition and intervention. The ability to differentiate between benign and lethal rhythms, understand their hemodynamic consequences, and apply the appropriate treatment protocol is essential for critical care nurses. Overview Cardiac dysthythmias result from disturbances in the heart's electrical conduction system. These disturbances may involve: ◦Automaticity: cells firing when they shouldn't (e.g., ectopic pacemakers in VT) ◦Conductivity: failure or delay in signal transmission (e.g., AV blocks) • Reentry circuits: impulses looping repeatedly through cardiac tissue (e.g., SVT) In critically ill patients, dysrhythmias often result from underlying myocardial ischemia, electrolyte disturbances (especially potassium K+, Magnesium Mg2+, Calcium Ca2+), hypoxia, or medication effects (e.g.) digoxin, antiarrhythmics). Common precipitating conditions include acute coronary syndrome, heart failure, and post-cardiac surgery states. The most clinically significant dyshythmias are those that impair cardiac output-either by excessively increasing or decreasing heart rate, reducing stroke volume (e.g., loss of atrial kick in atrial fibrillation), or causing uncoordinated contractions (e.g., ventricular fibrillation). Pathophysiology of Key Rhythms ◦Tachyarrhythmias (e.g., SVT, VT): Increase myocardial oxygen demand, reduce ventricular filling time → Decreased cardiac output CO, increased ischemia risk. ◦Bradyarrhythmias (e.g., sinus bradycardia, high-grade AV blocks): Slow heart rate → decreased Cardiac output CO → hypoperfusion. ◦Pulseless rhythms (e.g., VF, pulseless VT, asystole, PEA): No effective circulation → require immediate ACLS. ◦Atrial arrhythmias (e.g., afib/flutter): Loss of atrial contraction → preload, risk of thromboembolism. ◦Heart blocks: Delay or block signal from atria to ventricles → bradycardia or AV dissociation, depending on type. ◦ CCRN Exam Insight: Expect ECG strips, clinical vignettes, or questions asking for the next best step (e.g., cardioversion vs defibrillation, pacing vs atropine). Know how to recognize rhythms and interpret their hemodynamic impact. In summary, rhythm interpretation is not just about identifying the pattern-it's about linking it to perfusion status, underlying cause, and urgent interventions. This section will guide you through high-yield dysrhythmias and what to do when you see them-exactly what the CCRN wants to test. Signs/Labs The clinical recognition of dyshythmias depends on correlating vital signs, patient symptoms, and ECG patterns. In the ICU, patients with dysrhythmias often present with hemodynamic instability-such as hypotension, altered mental status, or sudden cardiac arrest. Understanding the clinical and electrocardiographic presentation of each rhythm is essential for rapid diagnosis and management. Clinical Signs & Symptoms The presentation of dysrhythmias varies based on the heart rate, rhythm origin, and impact on cardiac output: ◦Bradycardia (Heart Rate HR less than 60 bpm) ◦Fatigue, dizziness, lightheadedness Syncope or presyncope
Hypotension, especially in high-grade AV block or sinus node dysfunction ◦Possible altered mental status if cerebral perfusion drops ◦Tachycardia (heart rate greater than 100 bpm) ◦Palpitations, anxiety, chest discomfort ◦Shortness of breath (due to decreased filling time) ◦Hypotension or signs of poor perfusion if rate is excessive ◦Syncope in unstable or poorly tolerated rhythms ◦Syncope or sudden collapse ◦Seen in ventricular tachycardia, complete heart block, torsades de pointes, or VF ◦Always investigate arrhythmic causes in unexplained syncope in ICU patients ◦Pulses may be weak or irregular, and perfusion markers (e.g., urine output, skin color, cap refill) may deteriorate ◦ Electrocardiogram (ECG) Patterns ECG remains the cornerstone of dysrhythmia diagnosis. Recognizing key features of lethal and symptomatic rhythms is a must for the CCRN exam: ◦Ventricular Tachycardia (VT) ◦Wide QRS complexes (>0.12 sec), regular rhythm ◦May have pulse or be pulseless ◦Monomorphic or polymorphic (torsades) ◦Ventricular Fibrillation (VF) ◦Chaotic, irregular, no identifiable waves ◦No cardiac output-immediate defibrillation required ◦Supraventricular Tachycardia (SVT) ◦Narrow QRS, heart rate > 150 bpm ◦P waves often hidden in T waves ◦Sudden onset and termination ◦Atrial Fibrillation (Afib)
Irregularly irregular rhythm ◦No discernible P waves, variable ventricular response ◦Risk of thromboembolism ◦Atrial Flutter ◦Sawtooth flutter waves (best seen in leads II, III, aVF) ◦Ventricular rate often regular and fast (2:1 or 4:1 conduction) ◦AV Blocks ◦First-degree: prolonged PR interval (>0.20 sec) ◦Second-degree Mobitz I (Wenckebach): progressive PR prolongation → dropped beat ◦Second-degree Mobitz II: dropped beats without PR change ◦Third-degree (complete) block: atria and ventricles beat independently (AV dissociation) Key Exam Insight: You may be given a rhythm strip with subtle findings-look for clues like rate, regularity, QRS width, P wave presence, and PR interval. Always ask: Is this rhythm perfusing the patient? If not, what's the immediate intervention? Additional Labs and Monitoring Electrolytes (K+, Caz*): imbalances are common triggers for arrhythmias Drug levels: especially digoxin or antiarrhythmics Cardiac biomarkers: if ischemia is suspected Telemetry or continuous ECG monitoring: crucial in identifying intermittent or sudden-
onset rhythms Dysrhythmias are high-risk and high-frequency on the CCRN exam. Recognize their signs, interpret the ECG pattern, and be ready to intervene. Treatment The treatment of dysrhythmias in critically ill patients is guided by the ACLS (Advanced Cardiovascular Life Support) algorithms, which emphasize rapid recognition, assessment of perfusion status, and rhythm-specific interventions. The CCRN exam frequently tests your ability to choose the right treatment based on the rhythm and the patient's clinical stability. Pulseless Ventricular Tachycardia (VT) & Ventricular Fibrillation (VF) ◦These are shockable rhythms requiring immediate defibrillation. ◦Follow ACLS cardiac arrest algorithm: ◦Defibrillation: 200 J biphasic (or per device protocol) ◦CPR immediately after shock ◦Epinephrine 1 mg IV/IO every 3-5 minutes ◦Amiodarone 300 mg IV push, then 150 mg if refractory ◦Goal: restore perfusing rhythm as quickly as possible Unstable Tachycardias (e.g., SVT, Afib with RVR) ◦If patient shows signs of instability (hypotension, altered LOC, chest pain, shock): ◦Perform synchronized cardioversion ◦SVT or Afib: 100-200 J biphasic (adjust per rhythm) ◦ Sedation prior if patient is conscious ◦If stable: ◦SVT: Try vagal maneuvers first, then adenosine 6 mg IV push (follow with 20 mL flush); may repeat with 12 mg ◦Afib with RVR: Rate control with beta-blockers (e.g., metoprolol) or calcium channel blockers (e.g., diltiazem) Bradycardia (Symptomatic) ◦Initial step: assess perfusion-is the patient hypotensive, altered, diaphoretic? ◦First-line treatment: Atropine 0.5 mg IV, repeat every 3-5 minutes (max 3 mg) If atropine is ineffective: ◦Transcutaneous pacing immediately if unstable
Consider dopamine infusion (2-10 mcg/kg/min) or epinephrine infusion (2-10 mcg/min) if pacing not available ◦ For high-grade AV block or sick sinus syndrome, transvenous pacing may be needed Ventricular Tachycardia (with a pulse, stable) ◦Amiodarone 150 mg IV over 10 minutes, then maintenance infusion ◦Alternative options: procainamide or lidocaine depending on patient profile Torsades de Pointes (polymorphic VT with prolonged QT) ◦First-line: Magnesium sulfate 1-2 g IV over 5-20 minutes ◦If pulseless: defibrillate immediately General Principles ◦Always treat the patient, not the monitor-symptom severity guides urgency ◦In unstable patients, electricity comes first (defib or cardioversion) ◦In stable patients, prioritize medications and rhythm control ◦Review ACLS algorithms-they're fair game on the CCRN and often tested in clinical. scenarios Exam Tip: A patient with Afib and a heart rate of 160, BP 78/40, and altered mental status? Don't waste time with meds-go straight to synchronized cardioversion. Bradycardic patient with HR 30 and chest pain? Give atropine, then prep for pacing if no Your ability to prioritize interventions based on patient stability is critical both on the exam and in practice. Heart Failure & Cardiomyopathies Overview and Pathophysiology Heart failure (HF) and cardiomyopathies are common and high-yield topics on the CCRN exam because they're frequently encountered in the ICU and involve multiple system interactions. Heart failure occurs when the heart cannot pump blood effectively to meet the body's metabolic demands, leading to fluid overload, poor perfusion, and progressive organ dysfunction. There are two main types of heart failure based on ejection fraction (EF): • Systolic heart failure (HFrEF - heart failure with reduced ejection fraction): 0 EF < 40% ◦The heart has impaired contractility (pumping problem) ◦Common causes: myocardial infarction, dilated cardiomyopathy, chronic hypertension ◦Diastolic heart failure (HFpEF - preserved ejection fraction): 0 EF ≥ 50% ◦The heart has impaired relaxation and filling (stiff ventricle) ◦Common causes: aging, hypertension, LV hypertrophy, restrictive cardiomyopathy Despite different mechanisms, both result in decreased cardiac output (CO) and activation of harmful compensatory mechanisms: ◦Renin-Angiotensin-Aldosterone System (RAAS): ◦Activated in response to decreased renal perfusion ◦Promotes vasoconstriction and sodium/water retention → increase preload and afterload ◦Sympathetic Nervous System (SNS): ◦Increases heart rate and contractility in the short term ◦Chronic activation leads to increased myocardial oxygen demand, arrhythmias, and worsening heart failure ◦Ventricular remodeling: ◦Structural changes in the myocardium due to chronic volume or pressure overload ◦Leads to further dysfunction and poor prognosis if left unchecked Heart failure is also classified by location: • Left-sided HF: Pulmonary congestion (dyspnea, orthopnea, rales) • Right-sided HF: Systemic congestion (JVD, peripheral edema, hepatomegaly) Biventricular HF: Combination of both; common in advanced disease Cardiomyopathies refer to diseases of the heart muscle and are categorized into: ◦Dilated cardiomyopathy: Most common; leads to systolic dysfunction ◦Hypertrophic cardiomyopathy (HCM): Often genetic; diastolic dysfunction, sudden death ◦Restrictive cardiomyopathy: Least common; stiff ventricles with poor filling ◦Takotsubo (stress-induced) cardiomyopathy: Transient apical ballooning due to catecholamine surge CCRN exam insight: You will often see scenarios where patients with underlying HF decompensate due to infection, arrhythmias, poor medication adherence, or excessive fluid administration. Knowing how to distinguish between systolic vs diastolic patterns, and understanding compensatory responses, is key to choosing the correct interventions. In ICU patients, heart failure may present subtly or progress rapidly-prompt recognition and intervention can prevent multi-organ failure. Signs/Labs Recognizing the clinical signs and key laboratory findings of heart failure is critical for early diagnosis and appropriate management in the ICU. Heart failure can present with a wide range of symptoms depending on the type (systolic vs diastolic) and whether the left or right side of the heart is primarily affected. Often, signs overlap due to biventricular involvement. Left-Sided Heart Failure (more common): ◦Dyspnea (especially on exertion) ◦Orthopnea (difficulty breathing when lying flat) ◦Paroxysmal nocturnal dyspnea (waking up gasping for air) ◦Pulmonary rales/crackles on auscultation ◦Cough with pink frothy sputum (in acute pulmonary edema) ◦Fatigue and exercise intolerance ◦Elevated respiratory rate (tachypnea) Right-Sided Heart Failure: ◦Jugular venous distension (JD) ◦Peripheral edema (pitting, bilateral) Hepatomegaly and RUQ discomfort Ascites and weight gain • Anorexia or nausea (due to venous congestion) Biventricular Failure: ◦Combination of pulmonary and systemic symptoms ◦Common in advanced or prolonged disease Laboratory & Imaging Findings: ◦B-type Natriuretic Peptide (BNP) or NT-proBNP: ◦Elevated due to ventricular stretch and pressure overload
BNP > 500 pg/mL is strongly suggestive of decompensated HF ◦Useful for diagnosis and monitoring response to treatment ◦Echocardiogram: ◦Critical tool to evaluate ejection fraction (EF), chamber size, and valve function ◦EF < 40% confirms systolic dysfunction ◦Diastolic dysfunction may show preserved EF but impaired filling • Chest x-ray: ◦Pulmonary vascular congestion ◦Cardiomegaly ◦Kerley B lines (interstitial edema) ◦Pleural effusions in severe cases ◦Serum electrolytes: ◦Hyponatremia (marker of poor prognosis) ◦Hypokalemia or hyperkalemia (especially with diuretics or renal dysfunction) ◦Renal function (BUN/Cr): ◦May be elevated due to cardiorenal syndrome or diuretic use ◦Liver enzymes: ◦May be mildly elevated in right-sided failure from hepatic congestion CCRN tip: In a patient presenting with dyspnea and bilateral crackles, think of HF -BNP and echocardiogram will help confirm the diagnosis. Watch for JVD + peripheral edema in right-sided failure. Elevated BNP, low EF, and chest X-ray congestion are key triad findings for the exam. Treatment and Complications Management of heart failure in critically ill patients focuses on optimizing cardiac output, reducing fluid overload, preventing further cardiac damage, and addressing the underlying Cause. The approach varies depending on whether the patient is experiencing acute decompensation, cardiogenic shock, or chronic stable heart failure. Diuretics Loop diuretics (e.g., furosemide) are first-line in fluid-overloaded patients. ◦Rapidly relieve pulmonary and peripheral congestion ◦Monitor for electrolyte losses (especially potassium and magnesium) ◦Use IV route in acute settings for quicker onset ◦Watch for over-diuresis → hypotension, renal hypoperfusion ACE Inhibitors / ARBs Used in systolic heart failure to reduce afterload and improve survival. ◦Lower blood pressure and decrease cardiac workload ◦Prevent ventricular remodeling ◦Contraindicated in acute renal failure or hyperkalemia ◦Examples: enalapril, lisinopril, losartan (ARB) Beta-Blockers Essential for long-term management of systolic HF, but caution in acute decompensation. ◦Reduce heart rate and myocardial oxygen demand ◦Improve long-term outcomes and reduce mortality ◦Hold or reduce dose during acute decompensated HF with hypotension Inotropes (if signs of shock or low cardiac output) Used temporarily in severe systolic dysfunction with hypotension or shock. ◦Dobutamine: ß1 agonist → 1 contractility and CO ◦Milrinone: PDE inhibitor → I contractility, vasodilation ◦Use with caution: can cause arrhythmias or hypotension Noninvasive Ventilation (CPAP/BiPAP) Especially beneficial in patients with pulmonary edema and respiratory distress. ◦Improves oxygenation and reduces work of breathing ◦Decreases preload and afterload ◦May prevent need for intubation in select patients Other supportive measures ◦Sodium restriction and fluid restriction in volume overload Oxygen therapy as needed for hypoxia ◦Treat precipitating factors: ischemia, infection, arrhythmias, anemia ◦Anticoagulation if atrial fibrillation is present CCRN clinical decision point: In a patient with acute pulmonary edema, start IV furosemide and consider BiPAP immediately. If hypotension persists despite fluids, initiate dobutamine. Never start beta-blockers in active shock or decompensation-wait until stable. ACE inhibitors are great for chronic HF, but hold them if creatinine rises sharply. Cardiac Tamponade Overview and Pathophysiology Cardiac tamponade is a life-threatening emergency caused by accumulation of fluid, blood, or pus in the pericardial sac, which compresses the heart and restricts its ability to fill during diastole. This leads to decreased stroke volume, reduced cardiac output, and eventually obstructive shock. Prompt recognition and intervention are critical-this condition is a high-yield topic for the CCRN exam. Pathophysiology Under normal conditions, the pericardial space contains 15-50 mL of lubricating fluid. When this volume increases rapidly-as in trauma, post-cardiac surgery, or aortic dissection-the pericardium doesn't stretch fast enough to accommodate it. Even a small accumulation (100-200 mL) can cause tamponade if it occurs quickly. As pressure rises in the pericardial sac, it exceeds intracardiac pressures, especially during diastole. This restricts right atrial and right ventricular filling, reducing preload and ultimately impairing left ventricular output. Key result: obstructive shock due to impaired venous return and low cardiac output. Common Causes ◦Post-cardiac surgery (especially in the first 48-72 hours) ◦Penetrating or blunt chest trauma ◦Pericarditis with large effusion (e.g., viral, malignancy, TB, uremic) ◦Aortic dissection (retrograde blood into pericardium) ◦Post-MI (Dressler syndrome or free wall rupture) Why it's tested? The CCRN exam emphasizes tamponade due to its classic clinical signs, rapid deterioration, and need for urgent pericardiocentesis. ICU nurses must be able to recognize the triad of findings and act immediately. Clinical clue: Tamponade should always be suspected in a post-op cardiac surgery patient who becomes hypotensive, tachycardic, and has low output with rising CVP. It's a surgical emergency-don't delay. Signs/Labs Cardiac tamponade presents with a classic set of clinical and hemodynamic findings that must be quickly recognized to avoid cardiovascular collapse. These signs are considered "can't-miss" on the CCRN exam, especially in the context of post-cardiac surgery, trauma, or rapid hemodynamic deterioration. Beck's Triad The hallmark triad of tamponade, seen most clearly in trauma and surgical patients: • Hypotension - due to reduced stroke volume and impaired ventricular filling • Jugular venous distention (JVD) - from elevated right atrial pressure • Muffled or distant heart sounds - fluid in pericardial sac dampens transmission Other Key Signs • Pulsus paradoxus - an exaggerated drop in systolic BP (>10 mmHg) during inspiration. It reflects impaired left ventricular filling during inspiration due to septal shift. ◦Tachycardia - a compensatory response to low cardiac output ◦Narrow pulse pressure - systolic and diastolic pressures close together ◦Dyspnea or chest discomfort - often vague, especially in slow-onset cases ◦Decreased cardiac output (LCO) - results in fatigue, altered mental status, cool extremities ◦ Hemodynamic Clues If invasive monitoring is in place: ◦Elevated CVP and RAP with equalization of pressures across all chambers (CVP ≥ РАОР ~
PADP) ◦Low cardiac index ◦Electrical alternans on ECG - alternating QRS amplitudes, seen in large effusions ◦Low-voltage QRS complexes - due to fluid insulation CCRN exam tip: If you see hypotension + JVD + muffled heart sounds (especially post-cardiac surgery or trauma), tamponade is the answer. In ventilated patients, look for rising CVP with falling MAP and CO-this may be the only early clue. Pulsus paradoxus may also show up in questions testing your understanding of hemodynamics. Treatment and Complications Cardiac tamponade is a true ICU emergency. Management focuses on prompt recognition and rapid intervention to restore cardiac output. The definitive treatment is drainage of the pericardial fluid, but temporary measures may be necessary to stabilize the patient beforehand. Immediate Treatment • Pericardiocentesis: The definitive intervention. Involves insertion of a needle into the pericardial sac to aspirate fluid and relieve pressure on the heart. It can be performed blindly in emergent settings but is ideally done under ultrasound or fluoroscopic guidance. • Pericardial window (surgical): May be required in recurrent or loculated effusions, especially post-surgical patients or trauma cases. ◦Volume resuscitation (temporary measure):
Intravenous fluids (crystalloids) may be used to increase preload and temporarily improve cardiac output before drainage. This is a bridge, not a solution. ◦Vasopressors (if needed): decompression.
May be used short-term to maintain perfusion pressure, but should not delay pericardial Nursing Priorities Continuous hemodynamic monitoring (MAP, CVP, CO if available) ◦Prepare for pericardiocentesis (equipment, consent, positioning) ◦Maintain calm environment and closely monitor for sudden deterioration ◦Watch for changes in ECG and vital signs during/after fluid removal Common Complications ◦Cardiac arrest:
If tamponade is not relieved, progressive hypotension can lead to pulseless electrical activity (PEA) and death. This is a frequent exam scenario. ◦Recurrence:
If the pericardial effusion is not fully drained, or the underlying cause (e.g., bleeding, malignancy, infection) is not addressed, tamponade may recur. ◦Perforation:
Risk during pericardiocentesis-may cause myocardial or coronary vessel injury. ◦Arrhythmias:
Can occur due to irritation of the myocardium during needle insertion or due to sudden shifts in volume status. ◦ CCRN exam tip: A patient with hypotension, rising CVP, and muffled heart sounds post-CABG or trauma = tamponade. The correct answer is pericardiocentesis-not fluids, not vasopressors. If you see PEA arrest in this setting, assume tamponade and prepare for emergency drainage. Cardiogenic Shock Overview and Pathophysiology Cardiogenic shock is a high-mortality, exam-priority topic that reflects the ICU's most severe form of pump failure. It occurs when the heart is unable to generate adequate cardiac output (CO) to meet the body's metabolic demands, despite adequate intravascular volume. The result is systemic hypoperfusion, end-organ dysfunction, and rapid clinical decline. The most common cause of cardiogenic shock is acute myocardial infarction (MI)- particularly large anterior wall infarctions affecting the left ventricle. Other causes include end-stage heart failure, severe cardiomyopathy, valvular dysfunction, myocarditis, and arrhythmias. In the postoperative cardiac population, tamponade or severe RV failure may also lead to cardiogenic shock, Pathophysiology The hallmark of cardiogenic shock is decreased myocardial contractility, leading to: ◦Decrease Stroke Volume (SV) and decrease Cardiac Output (CO) ◦ Increase Left ventricular end diastolic pressure (LVEDP) → pulmonary congestion ◦Increase Systemic vascular resistance (SVR) due to compensatory vasoconstriction ◦Decrease Coronary perfusion → worsening ischemia → further decrease contractility As the heart fails to pump effectively, a vicious cycle begins: reduced CO causes hypotension - decreased coronary perfusion → further ischemia → further reduction in CO. Without intervention, this spiral leads to multi-organ dysfunction syndrome (MODS), arrhythmias, and death. Compensatory mechanisms like the sympathetic nervous system (SNS) and renin-angiotensin-aldosterone system [RAAS]) temporarily try to restore perfusion by increasing heart rate and SVR, but they also increase myocardial oxygen demand and afterload, further straining the failing heart. Key Hemodynamic Features: ◦decrease CO/CI ◦Increase CVP and increase PAOP (wedge pressure) - due to blood backing up into the pulmonary circulation ◦Increase SVR - vasoconstriction as a compensatory response ◦Decrease MAP - due to poor forward flow ◦ CCRN exam tip: Cardiogenic shock = pump failure → hypotension + pulmonary congestion + elevated filling pressures. Know the hemodynamic profile and causes. If you see elevated PAOP+ low CO + high SVR = cardiogenic shock. Now you know this should never happen on your watch! Signs/Labs Recognizing the clinical signs and hemodynamic profile of cardiogenic shock is critical for early diagnosis and intervention -especially in post-MI and critically ill cardiac patients. These findings often appear on the CCRN exam in scenario-based questions that test your understanding of shock physiology. Clinical Signs ◦Hypotension: Systolic BP typically <90 mmg or MAP <65 mmHg, despite adequate fluid ◦Cool, clammy skin: Result of peripheral vasoconstriction; a classic sign of poor perfusion. ◦Oliguria: Decreased urine output (<0.5 mL/kg/hr) due to reduced renal perfusion.
Altered mental status: Confusion, restlessness, or lethargy due to decreased cerebral perfusion. Tachycardia: Compensatory response by the sympathetic nervous system. • Pulmonary congestion: Dyspnea, crackles, and pink frothy sputum may be present due to left-sided failure and elevated pulmonary capillary pressures. Laboratory Findings • Increase Lactate: Reflects anaerobic metabolism and tissue hypoxia. A key marker of shock severity. Increase BNP or NI-proBINP: Suggests ventricular strain or fluid overload, often elevated in acute decompensated heart failure. ◦Increase Troponin: If shock is due to MI, troponin levels will be elevated. ◦Decrease Mixed venous oxygen saturation (SvOz): Indicates reduced oxygen delivery and extraction by tissues. Hemodynamic Profile (Invasive Monitoring) Increase Central Venous Pressure (CVP): Right-sided pressure elevation due to poor forward flow. ◦Increase Pulmonary Artery Occlusion Pressure (PAOP): Reflects high left-sided filling pressures. ◦Decrease Cardiac Output (CO) / Cardiac Index (CI): Core diagnostic criteria for cardiogenie shock. ◦Increase Systemic Vascular Resistance (SVR): A compensatory response to hypotension. CCRN insight: The hemodynamic triad- ICO, 1PAOP, SVR-is a hallmark of cardiogenic shock. Combine this with signs of poor perfusion (cool skin, oliguria, AMS) and you have the classic exam scenario. Always distinguish cardiogenic shock from hypovolemic or distributive shock based on these pressure readings. Treatment and Complications The treatment of cardiogenic shock focuses on restoring tissue perfusion, optimizing cardiac output, and correcting the underlying cause-usually myocardial infarction or severe heart failure. The management is delicate, as excessive fluids can worsen pulmonary edema, and aggressive vasopressors may increase afterload. Every intervention must be guided by invasive monitoring and clinical response. 1. Pharmacologic Support ◦Inotropes:
 First-line agents to improve myocardial contractility and enhance cardiac output. ◦Dobutamine: B1-agonist; increases contractility and cardiac output with minimal effect on blood pressure. May cause vasodilation, so hypotension must be monitored.
Milrinone (inodilator): Useful in patients on beta-blockers; reduces afterload and improves contractility. Vasopressors:
 Used when MAP <65 despite adequate volume and inotropic support.
Norepinephrine: First-line vasopressor for cardiogenic shock. Raises BP by increasing SVR while maintaining some inotropic activity.
Epinephrine: Can be considered if refractory hypotension; has more potent ß1 and a effects but may increase myocardial oxygen demand. 2. Volume Status and Fluids ◦Cautious fluid administration: If the patient is hypovolemic, small boluses (e.g., 250 ml) may be trialed with close monitoring. ◦Avoid large-volume resuscitation: Can lead to pulmonary congestion if the LV is failing. 3. Diuretics ◦Loop diuretics (e.g., furosemide) should only be used after perfusion is restored and Bp is stable. ◦In the presence of volume overload (JVD, crackles, weight gain), diuretics relieve pulmonary and systemic congestion. ◦Must be avoided in early shock when perfusion is low and the kidneys are at risk. 4. Mechanical Circulatory Support ◦Intra-Aortic Balloon Pump (IABP) ◦Inflates during diastole to improve coronary perfusion.
Deflates just before systole to reduce afterload and myocardial oxygen demand.
Used as a bridge to revascularization in MI or until transplant/LVAD in end-stage heart failure. ◦Other options (for advanced centers): ◦Impella, VA-ECMO: For refractory shock not responsive to medication. 5. Revascularization (if MI-related) • PCI or CABG: Reperfusion must be initiated urgently in patients with STEMI and cardiogenic shock. Early revascularization improves survival. 6. Monitoring and Nursing Priorities ◦Continuous hemodynamic monitoring: MAP, CI, CVP, PAOP. ◦Frequent assessment of mental status, urine output, lactate clearance. ◦Titration of vasoactive drugs based on perfusion parameters. CCRN exam tip: In cardiogenic shock, start with dobutamine to improve contractility. If BP drops too low, add norepinephrine. Only give diuretics if patient is volume overloaded and perfused. If the question mentions MI + shock → consider early PCI and IABP. Mechanical Circulatory Support Intra-Aortic Balloon Pump (IABP) The Intra-Aortic Balloon Pump (IABP) is a temporary mechanical circulatory support device used to assist patients with severe left ventricular dysfunction, most commonly in cardiogenic shock, refractory angina, or as a bridge to definitive therapy (e.g., PCI, CABG, or transplant). Though its use has declined with the rise of more advanced support (Impella, VA-ECMO), IABP remains a frequently tested device on the CCRN exam. Mechanism of Action The IABP consists of a catheter with an inflatable balloon, typically inserted into the femoral artery and positioned in the descending thoracic aorta, just distal to the left subclavian artery. arterial waveform triggers. It functions by inflating and deflating in sync with the cardiac cycle, controlled by ECG or ◦Inflation during diastole: Increases aortic diastolic pressure → augments coronary perfusion. ◦Deflation just before systole: Reduces aortic pressure before the heart ejects blood → decreases afterload and myocardial oxygen demand. This dual effect helps improve myocardial oxygen supply-demand balance and increase cardiac output by supporting forward flow. Indications Cardiogenic shock (especially post-MI with persistent low output) ◦Refractory unstable angina not responsive to medications ◦Bridge to PCI, CABG, or transplant
Mechanical complications of MI (e.g., papillary muscle rupture, VSD) ◦Weaning from cardiopulmonary bypass Contraindications • Severe aortic insufficiency (regurgitation will worsen) Aortic dissection • Significant peripheral arterial disease (relative) • Severe sepsis or bleeding disorders (risk of complications) Nursing Priorities and Monitoring ◦Timing: Balloon inflation/deflation must be properly synchronized with the cardiac cycle. Improper timing can worsen hemodynamics. ◦Inflation: Onset of diastole (dicrotic notch) ◦Deflation: Just before systole (R wave) ◦Limb checks: Monitor distal pulses (especially in the affected leg), color, temperature to detect limb ischemia. ◦Urine output: Monitor for reduced perfusion to kidneys if balloon is malpositioned. ◦Bleeding & infection risk: IABP is an invasive device-monitor for signs of bleeding at insertion site and systemic infection. Positioning: Patient must remain supine with HOB ≤30° to prevent catheter displacement. Logroll only. Complications ◦Limb ischemia (most common) ◦Aortic dissection or perforation ◦Bleeding or hematoma at insertion site • Balloon rupture (rare but serious-watch for blood in helium tubing) • Infection (especially with prolonged use) CCRN exam tip: If the question mentions IABP in a hypotensive patient, think of afterload reduction and coronary perfusion support. If diminished urine output and cold leg after IABP placement → suspect limb ischemia. If balloon is not inflating/deflating correctly, first check timing on arterial waveform or ECG trigger. Hemodynamic Monitoring - Essential Pressures Overview Swan-Ganz catheterization and invasive hemodynamic monitoring are high-yield topics on the CCRN exam. These tools assess preload, afterload, and cardiac output, essential for managing shock states, heart failure, and fluid balance. Key Values Parameter Normal Value What It Indicates CVP 2-6 mmHg Right-sided preload (volume status) PAP 15-25 / 8-15 mmHg Pulmonary artery pressures PAOP (Wedge) 6-12 mmHg Left-sided preload (LV function) CO 4-8 L/min Total cardiac output CI 2.5-4.2 L/min/m2 CO adjusted for body surface area SVR 800-1200 dynes/sec/cm5 Systemic vascular resistance (afterload) Signs of Key Conditions ◦Increase CVP + Increase PAOP = Fluid overload (e.g., CHF) ◦Increase PAOP + decrease CO = Cardiogenic shock ◦Decrease CVP + decrease PAOP = Hypovolemia ◦Decrease SVR + increase CO = Hyperdynamic sepsis ◦Increase SVR+ decrease CO = Vasoconstrictive or cardiogenic shock Treatment and Complications Treatment based on the hemodynamic profile: fluids, diuretics, vasopressors, inotropes • Complications of Swan-Ganz: arrhythmias, infection, pulmonary artery rupture, thrombosis Hypertensive Crisis Overview and Pathophysiology A Hypertensive Crisis is a clinical emergency marked by a sudden and severe elevation in blood pressure, typically with systolic BP > 180 mmHg and/or diastolic BP >120 mmHg. It is categorized into two distinct conditions, which are tested frequently on the CCRN exam: ◦Hypertensive Urgency: Severe BP elevation without acute target organ damage ◦Hypertensive Emergency: Severe BP elevation with evidence of acute organ damage (e.g., encephalopathy, MI, aortic dissection, AK) The distinction is critical, as hypertensive emergencies require immediate BP reduction to prevent further damage, while urgencies can be managed more conservatively. Pathophysiology Hypertensive crisis occurs when autoregulatory mechanisms in vital organs (brain, heart, kidneys) are overwhelmed by the acute rise in blood pressure. This leads to: ◦Endothelial injury and increased permeability ◦Vasoconstriction and microvascular thrombosis ◦Ischemia in organs with high perfusion demands (brain, myocardium, kidneys) The cerebral autoregulation curve shifts in patients with chronic hypertension, meaning rapid BP drops-even to "normal" levels— can cause cerebral hypoperfusion and ischemia. That's why rate of BP reduction matters more than the absolute number. Common Triggers include: • Abrupt withdrawal of antihypertensives (e.g., clonidine, beta-blockers) Acute kidney injury or renal artery stenosis • Preeclampsia/eclampsia Pheochromocytoma ◦Cocaine or stimulant use ◦Post-operative complications Target Organ Involvement in Hypertensive Emergency: ◦Neurologic: Hypertensive encephalopathy, stroke, intracranial hemorrhage ◦Cardiac: Acute coronary syndrome, heart failure, aortic dissection ◦Renal: AKI, proteinuria, hematuria Ophthalmologic: Papilledema, retinal hemorrhages CCRN Exam Insight: Know the difference between urgency and emergency, and which signs indicate end-organ damage (e.g, AMS = encephalopathy, chest pain = MI or dissection, decrease urine output UO= AKI). Treatment questions will often focus on gradual BP reduction in emergencies vs oral meds and observation in urgency. Signs & Treatment Clinical Presentation The signs and symptoms of a hypertensive crisis vary based on the presence or absence of target organ damage. Recognizing these red flags is critical for differentiating hypertensive urgency from hypertensive emergency-a distinction that directly influences treatment approach. Hypertensive Urgency ◦Severely elevated BP (usually > 180/120 mmHg) ◦No evidence of acute end-organ damage May be asymptomatic or present with:
Headache
Anxiety ◦Epistaxis Mild dyspnea Hypertensive Emergency ◦Severe BP elevation with acute end-organ damage, often life-threatening ◦Common presentations include: ◦Neurologic: Confusion, altered mental status, seizures, visual disturbances (encephalopathy or stroke) ◦Cardiac: Chest pain, signs of MI or acute heart failure ◦Renal: Oliguria, hematuria, elevated creatinine  Retinal: Papilledema, retinal hemorrhages CCRN Exam Clue: A patient with BP of 200/120 mmHg and confusion or visual changes = hypertensive emergency → needs IV treatment and ICU-level care. No symptoms = urgency - managed with oral meds and outpatient follow-up. Treatment Approach Hypertensive Emergency Goal: Reduce BP gradually to prevent ischemia from rapid perfusion drops. Initial target: Lower MAP (mean arterial pressure) by no more than 20-25% in the first hour. • Once stable, aim for BP ≥160/100 over the next 2-6 hours. IV Medications (ICU Only) • Nicardipine (1st line): Potent arterial vasodilator, easy titration, safe in most emergencies Labetalol: Alpha and beta-blocker; useful in aortic dissection, stroke ◦Esmolol: Ultra-short beta-blocker; used in aortic dissection ◦Nitroglycerin: For ACS or pulmonary edema (venodilator) ◦Sodium nitroprusside: Rapid action; avoid in renal/hepatic failure due to cyanide toxicity ◦Hydralazine: Used in preeclampsia/eclampsia; less predictable response Targeted Organ Protection ◦Neurologic: Avoid rapid BP drops in stroke (ischemic: lower BP only if >220/120 unless thrombolysis planned) ◦Cardiac: Manage ischemia with nitrates, beta-blockers ◦Aortic dissection: Rapid BP and HR control → Esmolol + nicardipine or nitroprusside ◦Preeclampsia/eclampsia: Labetalol or hydralazine + magnesium sulfate Hypertensive Urgency ◦No IV meds required. Use oral agents such as: ◦Captopril ◦Labetalol ◦Clonidine ◦Monitor BP over several hours and arrange follow-up within 24-48 hours. ◦ Exam Insight: The most common mistake is dropping BP too fast in hypertensive emergencies. For stroke, MI, or eclampsia, know which drug to use and how fast to lower the pressure. Always think "organ protection first, pressure second." Structural Heart Defects & Valve Disease Acquired Valve Disorders Overview and Pathophysiology Valvular heart disease is commonly encountered in ICU patients, particularly older adults and those with a history of rheumatic fever, degenerative changes, or infective endocarditis. Two of the most clinically significant valve disorders are aortic and mitral stenosis or regurgitation. These conditions may present as new murmurs, heart failure exacerbations, or hemodynamic instability in the critically ill-making them important for the CCRN exam. Aortic Stenosis (AS) ◦Narrowing of the aortic valve → increased afterload → left ventricular hypertrophy → eventual heart failure ◦Common in elderly due to calcific degeneration Fixed cardiac output state: cannot increase flow during exertion or hypotension Aortic Regurgitation (AR) ◦Incompetent aortic valve allows diastolic backflow into LV → volume overload → LV
dilation ◦Causes: endocarditis, aortic root dilation, bicuspid valve, trauma ◦Leads to widened pulse pressure, bounding pulses Mitral Stenosis (MS) ◦Obstruction to flow from LA → LV → increased LA pressure → pulmonary congestion → right heart failure ◦Most commonly due to rheumatic fever ◦Predisposes to atrial fibrillation and thromboembolism Mitral Regurgitation (MR) ◦Incompetent mitral valve → backflow into LA during systole → LV volume overload, increased LA pressure ◦Causes: ischemic papillary muscle dysfunction, myxomatous degeneration, endocarditis ◦Acute MR (e.g., after MI) can be rapidly fatal due to pulmonary edema and low forward output Signs & Symptoms ◦Aortic stenosis: Systolic murmur (crescendo-decrescendo), heard best at right 2nd
ICS, radiates to carotids; dyspnea, angina, syncope ◦Aortic regurgitation: Diastolic murmur, wide pulse pressure, bounding pulses, head bobbing (de Musset's sign) ◦Mitral stenosis: Diastolic rumble at apex with opening snap; dyspnea, orthopnea, hemoptysis ◦Mitral regurgitation: Holosystolic murmur at apex, radiates to axilla; signs of pulmonary edema, fatigue, palpitations Diagnostics ◦Echocardiogram: Key diagnostic tool-assesses valve function, gradients, chamber size, EF ◦CXR: May show cardiomegaly, pulmonary congestion ◦BNP: Often elevated in volume overload ◦Cardiac cath: Definitive hemodynamic assessment pre-valve surgery Treatment Overview ◦Medical management: Diuretics for volume overload, beta-blockers/ anticoagulation (esp. for MS + afib), afterload reduction (carefully in AR, MR) ◦Surgical: Valve repair or replacement (TAVR or open surgery), especially if symptomatic or EF is declining ICU considerations: Sudden decompensation may require inotropes, preload/afterload titration, or urgent surgery Exam tip: For Aortic Stenosis, avoid afterload-reducing agents (e.g., nitro) in hypotensive patients-cardiac output is fixed. For Mitral Stenosis, control rate if in afib and watch for signs of pulmonary congestion. A new murmur after MI? Think papillary muscle rupture (acute MR). TAVR - Transcatheter Aortic Valve Replacement Overview and Indications TAVR (Transcatheter Aortic Valve Replacement) is a minimally invasive procedure used to replace a stenotic aortic valve, primarily in patients with severe aortic stenosis who are high-risk or ineligible for open-heart surgery. It has become increasingly common in elderly ICU patients and is a high-yield topic for the CCRN exam, particularly regarding post-procedural monitoring and complications. Indications for TAVR include: ◦Severe symptomatic aortic stenosis (AS) ◦Advanced age, frailty, or comorbidities that make open surgical aortic valve replacement (SAVR)
high-risk ◦Patients with preserved or reduced EF, especially if symptomatic (syncope, angina, dyspnea) Procedure Overview ◦Performed in a hybrid OR or cath lab under sedation or general anesthesia ◦A catheter is inserted (usually via femoral artery) and advanced to the aortic valve ◦A balloon-expandable or self-expanding valve is deployed inside the native valve ◦The native calcified valve is left in place and compressed by the new prosthesis Post-TAVR ICU Priorities ◦Hemodynamic monitoring: Risk of hypotension from bleeding, tamponade, or conduction disturbances ◦Pacing readiness: TAVR can cause new-onset heart block due to proximity to the conduction system ◦Access site management: Monitor femoral site for hematoma, retroperitoneal bleed (signs:
hypotension, flank pain) ◦Neurologic checks: Risk of stroke due to embolization during valve deployment ◦Renal monitoring: Contrast load may worsen renal function, especially in elderly or those with pre-existing CKD Common Complications ◦Conduction abnormalities: New left bundle branch block (LBBB) or complete heart block → may require permanent pacemaker ◦Stroke: Embolic event from aortic arch manipulation ◦Aortic regurgitation: Paravalvular leak due to imperfect seal-often mild, but severe cases may need repeat intervention ◦Vascular complications: Femoral artery dissection, pseudoaneurysm, bleeding Valve malposition or embolization: Rare, but life-threatening Key ICU Considerations ◦Monitor ECG closely for new conduction changes post-procedure ◦Maintain MAP > 70-80 mmHg for adequate coronary and cerebral perfusion ◦Be alert for bradycardia or AV block-transvenous pacing may be required Evaluate breath sounds and oxygenation-flash pulmonary edema can develop in cases of valve malfunction or volume overload Exam tip: A patient who undergoes TAVR and develops bradycardia or a new wide QRS complex → think conduction block. Have pacer pads ready. Sudden hypotension after the procedure? Consider tamponade, access site bleed, or valve malposition. Common Complications (post-valve surgery) Valve replacement surgeries —whether surgical (SAVR) or transcatheter (TAVR) -carry a specific set of high-yield complications that CCRN candidates must recognize quickly. These complications can develop within hours or days post-op and may require immediate intervention. 1. Conduction Abnormalities ◦The aortic valve lies near the AV node and bundle of His. Surgery or valve expansion can damage conduction pathways. ◦Common post-op findings include new LBBB, prolonged PR intervals, or complete heart block. ◦Patients may require temporary or permanent pacemaker insertion, especially after TAVR. 2. Hemodynamic Instability ◦Hypotension post-op can stem from: ◦Tamponade (especially after SAVR): sudden hypotension + JD + muffled heart
sounds = Beck's triad.
Bleeding: internal (retroperitoneal, thoracic) or from access site (femoral artery with TAVR ◦Valve dysfunction: paravalvular leak or prosthetic valve dehiscence. 3. Valve Malfunction ◦Mechanical or bioprosthetic valves can become malpositioned, obstructed by thrombus, or lead to paravalvular regurgitation. ◦Echocardiography is the go-to tool for assessing valve integrity post-op. ◦Signs: recurrent dyspnea, hypotension, new murmur, or low cardiac output. 4. Embolic Events ◦Risk is highest in the first 72 hours post-op. ◦Stroke or TIA may result from manipulation of the aorta, thrombus formation on prosthetic surfaces, or dislodged calcific debris. Monitor neuro status closely; neuro checks every 1-2 hours in early post-op phase. 5. Respiratory Complications ◦Atelectasis and pulmonary edema are common post-op due to anesthesia, fluid shifts, or pre-existing HF. ◦In patients with impaired IV function, be alert for flash pulmonary edema. 6. Acute Kidney Injury (AKI) ◦Risk increased due to: ◦Use of contrast (TAVR)
Intra-op hypotension or low cardiac output ◦Comorbidities like DM or CKD ◦Monitor I&Os, BUN/Cr daily, and avoid nephrotoxic agents. 7. Infection ◦Sternal wound infections (SAVR) and catheter-related infections are possible. ◦Endocarditis is a late complication, more common in mechanical valves-look for fever, new murmur, 1WBC, TESR. 8. Thromboembolism and Anticoagulation ◦Mechanical valves require lifelong anticoagulation (warfarin). ◦Bioprosthetic valves typically need 3-6 months of anticoagulation or dual antiplatelet therapy. ◦Monitor INR, watch for bleeding signs, especially in elderly. CCRN Exam Insight: ◦A patient with new LBBB and bradycardia after TAVR = conduction block → prepare for pacemaker. ◦Sudden hypotension post-valve surgery = think tamponade or valve failure → stat echo. ◦Stroke after valve surgery? Assess time from procedure, check BP, and alert provider immediately. Post-Cardiac Surgery Complications CABG: Typical recovery and red flags Overview of CABG Recovery Coronary Artery Bypass Grafting (CABG) is a common open-heart procedure in ICU patients and a core topic on the CCRN exam. Understanding the normal post-op course and recognizing early signs of complications is critical for ICU nurses. Typical ICU recovery timeline includes: ◦Immediate post-op (first 6-12 hours): Close hemodynamic monitoring, chest tube drainage, weaning from ventilator, rewarming. Day 1-2: Extubation, ambulation, pain control, fluid shifts. • Day 3-5: Transition to step-down unit, stabilization of vital signs, wound healing, cardiac rehab initiation. Expected findings post-CABG: Temporary atrial arrhythmias (especially atrial fibrillation) Mild hypotension from rewarming/vasodilation Serosanguinous chest tube output (<150 mL/hr usually acceptable) ◦Decreased lung volumes due to atelectasis Red Flags to Recognize Immediately 1. Cardiac Tamponade ◦Beck's triad: hypotension, JD, muffled heart sounds
Sudden cessation of chest tube output ◦Narrow pulse pressure, rising CVP, electrical alternans on ECG ◦Requires urgent echocardiogram and pericardiocentesis 2. Bleeding • Chest tube output >150 mL/hr for 2+ consecutive hours, or sudden surge in output Signs of hypovolemia: tachycardia, hypotension, decreased urine output ◦Hemoglobin drop, altered clotting panel (PT, aPTT, platelets) ◦May require return to OR for surgical exploration 3. Arrhythmias ◦Atrial fibrillation most common (usually between days 2-3 post-op) ◦Monitor for rapid ventricular response (RVR), hypotension ◦Treat with beta blockers, amiodarone, or cardioversion if unstable ◦Ventricular arrhythmias: especially concerning if persistent-may signal ischemia, electrolyte issues, or graft failure 4. Graft Occlusion or Ischemia ◦Recurrence of chest pain, ST changes, ventricular arrhythmias ◦Often presents within 48 hours post-op ◦Requires urgent ECG, troponin, and possibly repeat angiography 5. Respiratory Complications ◦Atelectasis, pneumonia, or fluid overload ◦Look for increasing oxygen needs, crackles, or pulmonary edema on CXR 6. Infection ◦Incentive spirometry, chest physiotherapy are crucial ◦Fever >48 hrs post-op, elevated WBC, sternal wound drainage ◦Sternal wound infection (mediastinitis) is rare but serious 7. Neuro Changes ◦Culture wounds, start broad-spectrum antibiotics pending results ◦Delirium is common, especially in older adults ◦Stroke may occur due to aortic manipulation during surgery-monitor neuro checks frequently 8. Renal Dysfunction • Hypoperfusion, contrast use, or prolonged bypass time can lead to AKI • Monitor BUN/Cr and urine output closely CCRN Exam Insight: ◦Sudden drop in chest tube output + hypotension = suspect tamponade. ◦New-onset afib after day 2 = common but must be managed to prevent thromboembolism. ◦Chest tube output > 150 mL/hr x2 hrs? Call the provider-don't delay. CABG patients require constant surveillance in the ICU. Early detection of red flags can prevent deterioration and save lives-know this cold for the exam. Valve Replacement: Hemodynamic changes, arrhythmias Overview Valve replacement-either surgical or transcatheter-is a critical intervention for severe valvular disease (e.g., aortic stenosis, mitral regurgitation). Postoperative care involves intensive monitoring of hemodynamics, rhythm disturbances, and valve function, all frequently tested on the CCRN exam. Hemodynamic Changes After Valve Replacement ◦Aortic valve replacement (AVR):
Decreased afterload after stenotic valve is replaced → improved forward flow. ◦Watch for hypotension if the patient was preload-dependent pre-op. ◦Increased risk of coronary perfusion mismatch during early post-op phase. ◦Mitral valve replacement (MVR): ◦Sudden increase in left ventricular preload and afterload can stress the LV. ◦Monitor closely for pulmonary edema, especially if LV function is impaired. ◦Key monitoring points:
MAP goal: Typically, 65-80 mmHg, individualized per cardiac output.
PA catheter data (if used): Watch PAOP and CVP for fluid responsiveness.
New murmurs or hemodynamic instability may indicate valve malfunction, thrombosis, or perivalvular leak. Common Arrhythmias Post-Valve Surgery ◦Atrial fibrillation: ◦Occurs in up to 30-50% of patients, often within the first 2-4 days post-op. ◦Risk factors: age >65, prior afib, large left atrium, MVR.
Treat with rate control (beta blockers, amiodarone) and consider anticoagulation if sustained. ◦Heart blocks:
Particularly common after aortic or mitral valve surgery due to proximity to the conduction system. ◦AV block may require temporary or permanent pacemaker if persistent. ◦Ventricular arrhythmias: May indicate ischemia, electrolyte imbalances, or structural issues. ° Evaluate and correct underlying cause; treat per ACLS if unstable. Additional Considerations ◦Prosthetic valve types: ◦Mechanical valves require lifelong anticoagulation (e.g., warfarin). ◦Bioprosthetic valves may not require long-term anticoagulation but have a shorter lifespan. ◦Hemolysis risk: ◦Turbulent flow through prosthetic valves may lead to hemolysis -watch for anemia, schistocytes on smear, elevated LDH. ◦Infective endocarditis prevention: ◦Patients may require antibiotic prophylaxis before certain procedures. ◦Sudden bradycardia or heart block after valve surgery = think conduction system injury
→ pacing may be needed. ◦Post-op afib is expected-but don't ignore it. Assess hemodynamic impact and manage promptly. ◦Watch closely for hemodynamic instability, new murmurs, or elevated filling pressures-could signal prosthetic valve complication. Valve surgery patients need vigilant rhythm and pressure monitoring-your ability to catch subtle changes can make a lifesaving difference, both in the exam and at the bedside. Clinical Application & Scenarios Patient: 72-year-old female with Type 2 DM and HTN. Presented to ED with profound fatigue and "upset stomach" for 3 hours. She is diaphoretic and appears anxious. Vitals: BP 98/60, HR 52, RR 22, SpO2 92% on RA. EKG: Shows sinus bradycardia with 2mm ST-elevation in leads II, III, aVF. Question 1: What is the most likely diagnosis and why? A.) Unstable Angina B.) NSTEMI C.) Inferior STEMI D.) Non-cardiac etiology Answer: C.) Inferior STEMI. The EKG shows clear ST-elevation in two contiguous leads (II, III, aVF), which is diagnostic for STEMI. The symptoms, while atypical, are consistent with an acute event. Question 2: The patient's BP is 98/60. The provider orders sublingual Nitroglycerin. What is the priority nursing action? A.) Administer the medication as ordered. B.) Hold the medication and clarify the order with the provider. C.) Administer a 500mL fluid bolus first, then give the NTG. D.) Apply oxygen via nasal cannula at 4L/min before giving NTG. Answer: B.) Hold the medication and clarify the order. An inferior STEMI is highly associated with Right Ventricular (RV) involvement. RV infarction is preload-dependent. Nitroglycerin is a venodilator that reduces preload and can cause catastrophic hypotension in this scenario. The borderline BP is an additional red flag. Scenario 2 - The Post-PCI Patient Patient: 58-year-old male s/p PCI with drug-eluting stent for an anterior STEMI 2 days ago. He is on DAPT (ASA and Ticagrelor). He calls you to his room complaining of sudden, severe "ripping" chest pain that radiates to his back. His BP is 180/100 in the right arm and 110/70 in the left arm. Question: Based on this presentation, what is the most urgent concern? A.) Stent thrombosis B.) Recurrent STEMI C.) Aortic Dissection D.) Pericarditis Answer: C.) Aortic Dissection. The classic presentation of "ripping" chest pain radiating to the back, combined with a significant blood pressure differential between arms, is highly suggestive of an aortic dissection. This is a surgical emergency. While stent thrombosis (A) is a risk, the description of the pain and physical findings point decisively to dissection. Slide 12: Knowledge Check Questions Question 1: Which finding is most specific for diagnosing acute myocardial infarction? A.) Elevated CK-MB B.) Elevated White Blood Cell count C.) Elevated Troponin I D.) Elevated BNP Answer: C.) Elevated Troponin I. Troponin is highly specific to cardiac myocyte injury. While CK-MB (A) is also a cardiac marker, it is less specific. BNP (D) indicates heart failure stress, and WBC count (B) is a non-specific marker of inflammation. Question 2: A patient with an NSTEMI is being managed medically. Which assessment finding would most likely prompt the team to move to an early invasive (catheterization) strategy? A.) Stable chest pain, well-controlled with NTG. B.) A heart rate of 88 bpm. C.) New-onset crackles in the lung bases and increased oxygen requirement. D.) A blood pressure of 130/80. Answer: C.) New-onset crackles in the lung bases and increased oxygen requirement. This indicates the development of acute heart failure, which is a high-risk feature in NSTEMI that warrants urgent cardiac catheterization to identify and treat the culprit lesion. Refractory ischemia or hemodynamic instability shifts the strategy from ischemia-guided to early invasive.

Course Content

0 lessons · 0m total length

Reviews (1)